Xtandi 40 MG tablet 120S

Ended Awarded Last action

Contract number
SPE2DR26FCGA7
Awardee
Awarding agency
Obligated
$53,066

Award facts

Contract value 100% obligated
$53,065.92 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $53,065.92 delivery order to DMS Pharmaceutical Group Inc. on May 21, 2026, for XTANDI 40 mg tablets (120s) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

PPV-G GEN V is a single-award indefinite delivery contract with a $499.999 billion ceiling supporting pharmaceutical and medical consumable supply to Department of Defense military healthcare facilities worldwide. Place of performance is Park Ridge, Illinois. The delivery order carries an ultimate completion date of May 22, 2026, and is priced on a firm fixed-price basis.

DMS Pharmaceutical Group Inc. is a woman-owned small business.

Quick answers

Who was awarded contract SPE2DR26FCGA7?

SPE2DR26FCGA7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 21, 2026.

How much is contract SPE2DR26FCGA7 worth?

The government has obligated $53,066 on SPE2DR26FCGA7.

Is contract SPE2DR26FCGA7 an order under another contract?

Yes. SPE2DR26FCGA7 is a delivery order under SPE2DR25D9133, an indefinite delivery contract.

Was contract SPE2DR26FCGA7 competed?

The extent of competition for SPE2DR26FCGA7 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award